More Charts
2015 has not been a fun year for stock investors. In 2015, the S&P 500, which opened the year nearly at all-time highs, has made a new all-time high just 10 times. For a point of comparison, at this time last time at this year, the benchmark index had hit 27 fresh all-time records, and when 2014 was said and done, […]
Big outflows from U.S. stocks
What do April’s major mutual fund and ETF outflows tell us? Andrew Burkly of Oppenheimer and Boris Schlossberg of BK Asset Management discuss with Brian Sullivan.
Many investors appeared to ditch American stock funds in April, in the biggest exodus since the financial crisis. But far from taking that as a bad sign, some investors view the […]
Related CNCOppenheimer Boosting Targets In Healthcare On ‘Exposure To Interest Rate Changes’8 Managed Care Stocks To Watch In Earnings Season’Non-Cyclical Consumer Healthcare’: How This Sector Will Create Long-Term Wealth(Seeking Alpha)Related Biotech: Anatomy Of An Investing Mania?Bind Therapeutics Rallies Off Oppenheimer RatingIn separate reports, Oppenheimer analysts commented on the pipelines of two Biotech majors – Centene Corp (NYSE: CNC) and BIND […]
Sam Ro
Apr. 6, 2015, 6:51 AM
2,446
FinVizThe US stock markets will reopen Monday after enjoying a three-day weekend. However, US futures suggest it could be a rough trading session.Currently, Dow futures are down by around 135 points or 0.7%On Friday after a disappointing US jobs report, futures tanked with Dow, S&P and Nasdaq futures all falling by more than 0.9%. That […]
Trading Nation: How hot can biotech get?
David Seaburg, Cowen & Co., and Ari Wald, Oppenheimer, join “Power Lunch” to discuss the biotech rally.
Biotech stocks have been on fire. The industry has risen 40 percent in the past year, and added 2.3 percent on Friday alone. This after drug giant Biogen reported positive results for a new Alzheimer’s drug, leading its […]
Since its lows in mid-October, biotech stocks have sparkled, particularly the Big four – Amgen (AMGN), Biogen Idec (BIIB), Celgene (CELG), and Gilead (GILD) – which have demonstrated sustainable growth pathways. With the market’s renewed volatility in recent days, they have pulled back some, which only made them much more reasonably priced.But the more attractive buys in the sector, say […]
Wikimedia CommonsComing into 2014, Oppenheimer’s John Stoltzfus was one of the most bullish voices on Wall Street, making him one of the most accurate strategists in this surprisingly strong year.For 2015, strategists are expecting stocks to move even higher, and again, no one is more bullish than Stoltzfus. “We have initiated a target for the S&P 500 at the end of 2015 […]
Wikimedia CommonsComing into 2014, Oppenheimer’s John Stoltzfus was one of the most bullish voices on Wall Street, making him one of the most accurate strategists in this surprisingly strong year.For 2015, strategists are expecting stocks to move even higher, and again, no one is more bullish than Stoltzfus. “We have initiated a target for the S&P 500 at the end of 2015 […]
“If Oppenheimer is right with its downgrade I take it to mean that the market is reaching the end of the period of industrial outperformance that began with the strong labor reports from the fourth quarter,” Cramer explained. That’s critical, because as Cramer explained earlier in the week, immediately following recent jobs numbers many industrial stocks […]
